Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2003

View Archived Issues

CBT-1008 manufactured for preclinical studies

PVAC development for psoriasis discontinued

Approvable letter for Inspire's diquafosol tetrasodium ophthalmic solution

Novacea stops enrollment in DN-101 trial for MDS

Canadian notice of noncompliance for Statex

CPMP rejects PharmaMar appeal regarding Yondelis

Connetics submits NDA for Actiza

Eisai submits MAA for rapid dissolve Aricept in U.K.

GTI-2501 enters phase II

Sixteenth Medarex fully human antibody enters clinical development

Pivotal urban ambulance trial cleared to begin for PolyHeme(R)

PMA filing commences for OrCel for venous leg ulcers

Phase III doripenem trial commences enrollment

Enrollment completed in phase IIa study of PCK-3145

European orphan drug designation for gimatecan for glioma

Topical tacrolimus reported effective for oral lichen planus and facial psoriasis

Potential clinical benefits of CAI in ovarian cancer

France is first country to approve oral thrombin inhibitor

Series of phosphonates able to modulate apolipoprotein E described by Ilex

New stimulators of guanylate cyclase described in Bayer patent

New King Pharmaceuticals patent claims adenosine A3 receptor antagonists

Broad spectrum antiparasitics prepared at the University of Mississippi

Otsuka describes novel thiourea derivatives for diabetes and obesity

Tributyrin induces apoptosis of leukemia cell lines

FR-181157 shows potent PGI2 agonist activity and good pharmacokinetic profile

JNJ-10329670 represents a new class of immunosuppressive compounds

Health officials prepare for SARS resurgence, review treatment options

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...